Received: 7 July 2020
Accepted: 8 October 2020
First Online: 16 October 2020
Ethics approval and consent to participate
: The appropriate Institutional Review Board approved the study in accordance with the declaration of Helsinki (CE SRLF 19-15) and the French data protection authority (CNIL, authorization no. 2211482, Paris, France). The need for informed consent was waived due to the retrospective design of the study.
: Not applicable.
: Dr. Oudard reported expert testimony and consultancy fees and/or provided lectures for Pfizer, Bayer, MSD, Novartis, IPSEN and Merck.Dr. Michot reported advisory board membership for Bristol-Myers Squibb, Pfizer, Roche, Novartis, Janssen, AstraZeneca, Celgene, and Gilead.Dr. Lambotte reported expert testimony and consultancy fees from Bristol-Myers Squibb France, MSD, and AstraZeneca; consultancy fees from Genzyme; and expert testimony fees from Janssen.No other disclosures were reported.